1. Home
  2. All topics: A to Z
  3. Antimicrobial consumption
  4. Surveillance and disease data
  5. Antimicrobial consumption database
  6. Geographical distribution

Geographical distribution of antimicrobial consumption

DAMC04
 
 
Displaying a map for a particular year: Select only the button "start year".
TESSy calculates the limits of the five equidistant levels using the range of values for the selected year. This method maximizes the distribution of the countries into the five levels by calculating the limits for each year.
 
Displaying maps to compare the contrast between different years: Select the buttons "start year" and "end year".
TESSy calculates the limits of the five equidistant levels using the range of values for all selected years. This method is adapted for comparison between different years as the same limits are used for all years.
Geographical distribution of the consumption of Antibacterials for systemic use (ATC group J01) in the community (primary care sector) in Europe, reporting year 2017
Consumption of Antibacterials for systemic use (ATC group J01) in the community (primary care sector) in Europe, reporting year 2017
Liechtenstein
 
Luxembourg
 
Malta
 
No data reported
 
Not included
 
 
DDD per 1000 inhabitants and per day
  
0
 
13.583 to < 18.224
 
22.865 to < 27.507
  
8.941 to < 13.583
 
18.224 to < 22.865
 
27.507 to 32.148
       
Cyprus, Romania provided only total care data.
References:
1. Sub-classification of macrolides:
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45.
2. Sub-classification of quinolones
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi47-56.
3. Classification of antivirals for systemic use based on their main indication
Adriaenssens N, Coenen S, Kroes AC, Versporten A, Vankerckhoven V, Muller A, et al. European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother. 2011 Aug;66(8):1897-905.
General comments for comparison of antimicrobial consumption data from different countries and/or years:
Total care includes data both from the hospital sector and community (primary care sector) and overestimates the figures when used for reporting for the community sector.
Some countries report reimbursement data that do not include consumption of antimicrobials obtained without prescription and other non-reimbursed courses.
For more information please see the report "Data source overview of antimicrobial consumption"
Finland: hospital sector data include consumption in remote primary health care centres and nursing homes, thus overestimating hospital consumption and underestimating community consumption compared to the other countries that report data from these sources as community consumption.
This report has been generated from ESAC-Net data submitted to TESSy, The European Surveillance System on 2019-10-14. The report reflects the state of submissions in TESSy as of 2019-10-14 at 20:01
Page last updated 10 Jul 2017